To separate the direct effects of DYRK1A inhibition from these off-target effects, in the present study, we examined the effects of direct modulation of DYRK1A expression in the brain on cognitive function and AD pathology as well as the underlying molecular mechanisms. The gene discussed is DYRK1A; the disease is Alzheimer disease.